Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-Blind, Placebo-Controlled, Crossover On-Road Driving Study Assessing the Effect of JZP-110 on Driving Performance in Subjects With Excessive Sleepiness Due to Obstructive Sleep Apnea

Next Previous
X
Search
Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Crossover On-Road Driving Study Assessing the Effect of JZP-110 on Driving Performance in Subjects With Excessive Sleepiness Due to Obstructive Sleep Apnea

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 13 Dec 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Solriamfetol (Primary)
  • Indications Sleep apnoea syndrome
  • Focus Therapeutic Use
  • Acronyms OSA Driving Study
  • Sponsors Jazz Pharmaceuticals Inc

    • Most Recent Events

    • 10 Dec 2022 Results of pooled analysis from two phase 2 studies (NCT02806895, EudraCT 2015-003930-28, NCT02806908, EudraCT 2015-003931-36) published in the Neurology and Therapy
    • 03 Jan 2020 Status changed from recruiting to completed.
    • 12 Mar 2018 Planned End Date changed from 1 Feb 2017 to 1 Oct 2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top